tyrosine has been researched along with Triple Negative Breast Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coates, PJ; Nenutil, R; Stenckova, M; Vojtesek, B | 1 |
| Gao, GS; Guo, XJ; Jia, YM; Li, YQ; Qian, XL; Song, YM; Sun, YY; Wang, J; Wang, XZ; Xia, XQ; Xue, HQ; Zhang, XM | 1 |
| Chen, Y; Deng, L; Guo, Y; Li, P; Liu, Y; Luo, J; Pan, Y; Tong, T; Wang, B; Xiao, Y; Ye, L; Zhu, C; Zou, H | 1 |
| Dai, B; Fan, M; Ghauri, MA; Su, Q; Ullah, A; Wang, B; Wang, J; Zhan, Y; Zhang, D; Zhang, Y | 1 |
| Chen, J; Chen, X; Deng, G; He, L; Huang, X; Li, F; Li, S; Lin, C; Liu, Q; Ouyang, Y; Song, L; Wang, X; Wu, X; Xiao, Y; Yang, M | 1 |
| Bi, J; Shi, M; Zeng, X; Zhang, Y; Zhu, H | 1 |
| Chen, WL; Du, L; Le, TP; Li, J; Mahdi, F; Nagle, DG; Swanson, SM; Watabe, K; Zhou, YD | 1 |
| Han, L; Hawke, DH; Hu, Q; Hu, Z; Hung, MC; Li, C; Liang, H; Liang, K; Lin, A; Lin, C; Ma, G; Marks, JR; Park, PK; Wang, C; Wang, S; Wei, Y; Xing, Z; Yang, L; Zhang, Y; Zhou, J; Zhou, Y | 1 |
| McDonnell, S; Payan, I; Steelant, WF; Torres, HM; Van Slambrouck, S | 1 |
| Carneiro, B; Chae, YK; Chen, H; Gagliato, Dde M; Giles, FJ; Gonzalez-Angulo, AM; Hortobagyi, G; Liu, S; Mohindra, N; Pai, SG; Ramakrishnan-Geethakumari, P; Sohn, J; Ueno, N | 1 |
10 other study(ies) available for tyrosine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative Breast Cancer.
Topics: Cell Line, Tumor; Humans; Phenotype; Phosphorylation; Serine; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tyrosine | 2022 |
STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression.
Topics: Ataxia Telangiectasia Mutated Proteins; B7-H1 Antigen; Biomarkers, Tumor; Humans; Immune Checkpoint Inhibitors; Ligands; Lymphocytes, Tumor-Infiltrating; Mutation; Prognosis; Programmed Cell Death 1 Receptor; STAT1 Transcription Factor; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tyrosine | 2022 |
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Humans; Kruppel-Like Transcription Factors; Protein-Tyrosine Kinases; Proteomics; src-Family Kinases; Transcription Factors; Triple Negative Breast Neoplasms; Tyrosine | 2023 |
Sanguinarine disrupts the colocalization and interaction of HIF-1α with tyrosine and serine phosphorylated-STAT3 in breast cancer.
Topics: Benzophenanthridines; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoquinolines; Phosphorylation; Protein Binding; Serine; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tyrosine | 2020 |
HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer.
Topics: Animals; beta Catenin; Cell Line, Tumor; Female; Homer Scaffolding Proteins; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Triple Negative Breast Neoplasms; Tyrosine | 2021 |
ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer.
Topics: Annexin A2; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gene Knockdown Techniques; Humans; Phosphorylation; Protein Kinase Inhibitors; Triple Negative Breast Neoplasms; Tyrosine | 2018 |
Biochemical and Anti-Triple Negative Metastatic Breast Tumor Cell Properties of Psammaplins.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aquatic Organisms; Cell Line, Tumor; Cell Proliferation; Culture Techniques; Disulfides; Drug Discovery; Drug Screening Assays, Antitumor; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Porifera; Spheroids, Cellular; Triple Negative Breast Neoplasms; Tyrosine | 2018 |
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer.
Topics: Animals; Cell Line, Tumor; Cytoplasm; E1A-Associated p300 Protein; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Heparin-binding EGF-like Growth Factor; Humans; Hydroxylation; Hypoxia-Inducible Factor 1, alpha Subunit; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Membrane Glycoproteins; Mice, Nude; Multiprotein Complexes; Neoplasm Proteins; Phosphorylation; Prognosis; Proline; Protein Serine-Threonine Kinases; Protein Stability; Protein-Tyrosine Kinases; RNA Interference; RNA, Long Noncoding; Serine; Signal Transduction; Time Factors; Transcription, Genetic; Transfection; Triple Negative Breast Neoplasms; Tyrosine | 2016 |
FAK tyrosine 407 organized with integrin αVβ5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Focal Adhesion Kinase 1; Humans; Phosphorylation; Receptors, Vitronectin; Triple Negative Breast Neoplasms; Tyrosine | 2016 |
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Phosphorylation; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-met; Receptor, ErbB-2; Triple Negative Breast Neoplasms; Tyrosine | 2016 |